Verdict Medical Devices

Cadrenal and Abbott sign agreement for LVAD trial of tecarfarin

Cadrenal Therapeutics has partnered with Abbott for the TECH-LVAD trial to assess the safety and efficacy of tecarfarin in LVAD patients. The post Cadrenal and Abbott sign agreement for LVAD trial of tecarfarin appeared first on Medical Device Network.

Mar 5, 2025 - 13:03
 0
Cadrenal and Abbott sign agreement for LVAD trial of tecarfarin
Cadrenal Therapeutics has partnered with Abbott for the TECH-LVAD trial to assess the safety and efficacy of tecarfarin in LVAD patients.

The post Cadrenal and Abbott sign agreement for LVAD trial of tecarfarin appeared first on Medical Device Network.

Read More

Tags:

Previous Article

FDA clears Epredia’s digital pathology solution

Next Article

How to Buy Safemoon: A Simple Guide for Crypto Beginners

Related Posts

Getinge’s surgical perfusion market exit ‘opens door’ for LivaNova

Getinge’s surgical perfusion market exit ‘opens door’ f...

Feb 22, 2025  0

FDA clears Tandem’s Control-IQ+ technology for type 2 diabetes

FDA clears Tandem’s Control-IQ+ technology for type 2 d...

Feb 26, 2025  0

WSU researchers develop algorithm to improve health wearable accuracy

WSU researchers develop algorithm to improve health wea...

Feb 24, 2025  0